User contributions
From OncoWiki
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)
- 05:22, 27 August 2018 (diff | hist) . . (+1,614) . . SMILE (current)
- 01:44, 27 August 2018 (diff | hist) . . (+10) . . m Lymphoma Hodgkin's, Adult (→Frontline) (current)
- 13:06, 14 June 2017 (diff | hist) . . (+931) . . N BeGeV (Created page with "== Hodgkin disease == salvage regimen in relapsed Hodgkin's lymphoma == Regimen == phase II study * Gemcitabine 800 mg/m2 on days 1 and 4 * Vinorelbine 20 mg/m2 on day 1, *...") (current)
- 12:57, 14 June 2017 (diff | hist) . . (+14) . . Lymphoma Hodgkin's, Adult (→Salvage)
- 02:03, 21 September 2016 (diff | hist) . . (+593) . . Flu Bu ATG - Slavin (current)
- 02:02, 21 September 2016 (diff | hist) . . (+316) . . N Flu Bu ATG - Slavin (Created page with "*Fludarabine (Fludara) 30 mg/m<sup>2</sup> IV once per day on days -10 to -5 (6 consecutive days) *Busulfan (Myleran) 4 mg/kg/day PO on days -6 to -5 (2 consecutive da...")
- 01:55, 21 September 2016 (diff | hist) . . (+1) . . m Stem Cell Transplantation (→Non-myeloablative conditioning regimens) (current)
- 01:54, 21 September 2016 (diff | hist) . . (+23) . . Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 20:21, 6 July 2016 (diff | hist) . . (+2,303) . . N Flu Bu ATG for Haplo (Created page with "== Regimen == *Busulfan (Busulfex, Otsuka Pharmaceuticals) 3.2 mg/kg per day intravenously on days −7 and −6 *Fludarabine 30 mg/m2 per day intravenously on days −7 to...") (current)
- 20:07, 6 July 2016 (diff | hist) . . (+1) . . m Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 20:06, 6 July 2016 (diff | hist) . . (+25) . . Stem Cell Transplantation (→Non-myeloablative conditioning regimens)
- 21:52, 16 May 2016 (diff | hist) . . (+1,666) . . N R-MPV (Created page with "== Regimen == IV Rituximab 500 mg/m2 day 1 IV Methotrexate 3.5 mg/m2 (over 2hours) day 2 IV Vincristine 1.4 mg/m2 (capped at 2.8mg)day 2 Procarbazine 100 mg/m2 /day was gi...") (current)
- 21:45, 16 May 2016 (diff | hist) . . (+4) . . m Lymphoma Non-Hodgkin's, Adult (→Primary CNS Lymphoma) (current)
- 21:44, 16 May 2016 (diff | hist) . . (+10) . . Lymphoma Non-Hodgkin's, Adult (→Primary CNS Lymphoma)
- 02:18, 18 April 2016 (diff | hist) . . (+1,734) . . N VDT-PACE (VDTPACE) (current)
- 01:50, 18 April 2016 (diff | hist) . . (+1) . . m Multiple Myeloma And Plasma Cell Dyscrasias (→Combinations) (current)
- 01:50, 18 April 2016 (diff | hist) . . (+13) . . m Multiple Myeloma And Plasma Cell Dyscrasias
- 22:01, 1 May 2014 (diff | hist) . . (+35) . . m Lymphoma Non-Hodgkin's, Adult (→Aggressive NHL)
- 21:54, 1 May 2014 (diff | hist) . . (+113) . . m Brentuximab vedotin (→Brentuximab vedotin (Adcetris)) (current)
- 21:53, 1 May 2014 (diff | hist) . . (+1,048) . . m Brentuximab vedotin (→Regimen)
- 21:50, 1 May 2014 (diff | hist) . . (+334) . . N Brentuximab vedotin (Created page with "==Brentuximab vedotin (Adcetris)== ===Regimen=== *Brentuximab vedotin (Adcetris) 1.8 mg/kg IV over 30 minutes on day 1 Supportive medications: *Rothe et al. 2012: "no p...")
- 21:49, 1 May 2014 (diff | hist) . . (+28) . . m Lymphoma Hodgkin's, Adult (→Salvage)
- 03:36, 30 October 2013 (diff | hist) . . (-25) . . m Adrenocortical Carcinoma (current)
- 03:35, 30 October 2013 (diff | hist) . . (+25) . . m Adrenocortical Carcinoma
- 03:16, 30 October 2013 (diff | hist) . . (+52) . . m Adrenocortical Carcinoma (→References)
- 03:13, 30 October 2013 (diff | hist) . . (-61) . . m Adrenocortical Carcinoma (→References)
- 03:12, 30 October 2013 (diff | hist) . . (+127) . . m Adrenocortical Carcinoma (→References)
- 03:10, 30 October 2013 (diff | hist) . . (+879) . . m Adrenocortical Carcinoma (→References)
- 03:07, 30 October 2013 (diff | hist) . . (+344) . . m Adrenocortical Carcinoma
- 03:01, 30 October 2013 (diff | hist) . . (+128) . . m Adrenocortical Carcinoma
- 02:44, 30 October 2013 (diff | hist) . . (+822) . . Adrenocortical Carcinoma (→Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy)
- 02:43, 30 October 2013 (diff | hist) . . (+803) . . m Adrenocortical Carcinoma (→Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy)
- 02:41, 30 October 2013 (diff | hist) . . (+67) . . N Adrenocortical Carcinoma (Created page with "=Adrenal gland tumors, adrenocortical carcinoma - adjuvant therapy=")
- 02:34, 30 October 2013 (diff | hist) . . (+642) . . N OncoWiki:General disclaimer (Created page with "Information on this website is meant only for Healthcare Practitioners. Use of any information obtained from this website is entirely at the user's discretion. You are advised...") (current)
- 02:34, 30 October 2013 (diff | hist) . . (+192) . . N OncoWiki:About (Created page with "This site will serve as a free repository for oncology information, chemotherapy protocols and cancer treatment regimens and is meant for Healthcare providers working in the f...") (current)
- 09:46, 26 October 2013 (diff | hist) . . (+26) . . Main Page (current)
- 07:28, 29 August 2013 (diff | hist) . . (+5) . . m EPOCH-DA (→References) (current)
- 07:21, 29 August 2013 (diff | hist) . . (+759) . . m EPOCH-DA
- 07:20, 29 August 2013 (diff | hist) . . (+20) . . m EPOCH-DA (→Dose adjustments)
- 07:19, 29 August 2013 (diff | hist) . . (+405) . . m EPOCH-DA
- 07:18, 29 August 2013 (diff | hist) . . (+5) . . m EPOCH-DA (→Supportive medications)
- 07:16, 29 August 2013 (diff | hist) . . (+5) . . m EPOCH-DA (→Supportive medications)
- 07:16, 29 August 2013 (diff | hist) . . (+117) . . m EPOCH-DA (→Supportive medications)
- 07:15, 29 August 2013 (diff | hist) . . (+113) . . m EPOCH-DA (→Supportive medications)
- 07:15, 29 August 2013 (diff | hist) . . (+31) . . EPOCH-DA (→Regimen)
- 07:14, 29 August 2013 (diff | hist) . . (+32) . . m EPOCH-DA (→Regimen)
- 07:14, 29 August 2013 (diff | hist) . . (+169) . . m EPOCH-DA (→Regimen)
- 07:13, 29 August 2013 (diff | hist) . . (+114) . . m EPOCH-DA (→Regimen)
- 07:05, 29 August 2013 (diff | hist) . . (+45) . . m EPOCH-DA (→Regimen)
- 07:04, 29 August 2013 (diff | hist) . . (+110) . . m EPOCH-DA (→Regimen)
- 07:03, 29 August 2013 (diff | hist) . . (+82) . . m EPOCH-DA (→Regimen)
- 07:02, 29 August 2013 (diff | hist) . . (+45) . . N EPOCH-DA (Created page with "== Regimen == R-EPOCH-DA: Dose Adjusted EPOCH")
- 06:53, 29 August 2013 (diff | hist) . . (+17) . . Lymphoma Non-Hodgkin's, Adult (→Aggressive NHL)
- 09:31, 16 August 2013 (diff | hist) . . (+1) . . Clofarabine, cyclophosphamide and etoposide (→Regimen) (current)
- 03:58, 9 October 2012 (diff | hist) . . (+66) . . Acute Myeloid Leukemia,Adult (→Post-remission regimens) (current)
- 03:57, 9 October 2012 (diff | hist) . . (+47) . . Acute Myeloid Leukemia,Adult (→Induction regimens)
- 03:57, 9 October 2012 (diff | hist) . . (+1,430) . . N Cytarabine Idarubicin Vorinostat induction (Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) induction== ===Regimen=== *Vorinostat (Zolinza) 500 mg PO TID on days 1-3 *Cytarabine (Cytosar) 150...") (current)
- 03:56, 9 October 2012 (diff | hist) . . (+1,281) . . N Cytarabine Idarubicin Vorinostat consolidation (Created page with "==Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) consolidation== Preceded by Cytarabine_Idarubicin_Vorinostat_induction therapy. ===Regimen=== *[[Vorin...") (current)
- 03:55, 9 October 2012 (diff | hist) . . (-116) . . m Vorinostat (→Vorinostat (Zolinza) maintenance) (current)
- 03:53, 9 October 2012 (diff | hist) . . (+938) . . N Vorinostat (Created page with "==Vorinostat (Zolinza) maintenance== Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idaru...")
- 03:53, 9 October 2012 (diff | hist) . . (+19) . . Acute Myeloid Leukemia,Adult (→Post-remission regimens)
- 03:02, 8 October 2012 (diff | hist) . . (-50) . . m BEAC (→Regimen) (current)
- 03:02, 8 October 2012 (diff | hist) . . (+1,121) . . N BEAC (Created page with "BEAC: '''<u>B</u>'''iCNU, '''<u>E</u>'''toposide, '''<u>A</u>'''ra-C, '''<u>C</u>'''yclophosphamide ===Regimen === ''Autologous blood stem cells are infused on day 0.'' *[[Car...")
- 02:49, 8 October 2012 (diff | hist) . . (+2,934) . . BEAM (→Regimen) (current)
- 02:00, 8 October 2012 (diff | hist) . . (+107) . . m BEAM (→Regimen)
- 01:52, 8 October 2012 (diff | hist) . . (-2) . . m BEAM (→Regimen)
- 01:48, 8 October 2012 (diff | hist) . . (+1,010) . . N BEAM (Created page with "===Regimen=== ''Day 0 is the day of transplantation.'' *Carmustine 300 mg/m2 IV on day -6 *Etoposide ) 200 mg/m2 IV BID on days -5 to -2 *Cytarabine ) 200 mg/m2 I...")
- 01:46, 8 October 2012 (diff | hist) . . (+4) . . m Stem Cell Transplantation (→Autograft regimens)
- 01:46, 8 October 2012 (diff | hist) . . (+19) . . Stem Cell Transplantation (→Autograft regimens)
- 01:39, 8 October 2012 (diff | hist) . . (+33) . . Cytotoxic Regimens (→External Links) (current)
- 03:41, 30 September 2012 (diff | hist) . . (+47) . . m Main Page (→Editors)
- 08:27, 27 August 2012 (diff | hist) . . (+4) . . APL4 - ALLG (→References) (current)
- 08:24, 27 August 2012 (diff | hist) . . (+4) . . m APL4 - ALLG (→References)
- 08:24, 27 August 2012 (diff | hist) . . (+3,041) . . N APL4 - ALLG (Created page with "== Regimen == '''Induction''' ATRA 45mg/m2/d PO Days 1-36 in divided doses Idarubicin 12mg/m2/d IV(ages 1-60) Days 2,4,6,and 8 9mg/m2/d IV (ages 61-70) 6mg/m2/d IV (ag...")
- 08:23, 27 August 2012 (diff | hist) . . (0) . . Acute Myeloid Leukemia,Adult (→APL Regimens)
- 08:10, 27 August 2012 (diff | hist) . . (+20) . . Acute Myeloid Leukemia,Adult (→APL Regimens)
- 23:30, 26 May 2012 (diff | hist) . . (-1) . . m CLAG-M (current)
- 23:29, 26 May 2012 (diff | hist) . . (+443) . . ATRA plus As203 (current)
- 23:25, 26 May 2012 (diff | hist) . . (+4) . . m CLAG-M
- 23:24, 26 May 2012 (diff | hist) . . (+5) . . CLAG-M
- 23:24, 26 May 2012 (diff | hist) . . (+969) . . N CLAG-M (Created page with "== Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine (2-CdA) 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs star...")
- 23:22, 26 May 2012 (diff | hist) . . (0) . . m Acute Myeloid Leukemia,Adult (→Salvage Regimens)
- 23:21, 26 May 2012 (diff | hist) . . (+4) . . m Acute Myeloid Leukemia,Adult (→Salvage Regimens)
- 23:21, 26 May 2012 (diff | hist) . . (+11) . . Acute Myeloid Leukemia,Adult (→Salvage Regimens)
- 10:01, 26 February 2012 (diff | hist) . . (+65) . . FOLFIRINOX (current)
- 10:00, 26 February 2012 (diff | hist) . . (+1,094) . . FOLFIRINOX
- 09:58, 26 February 2012 (diff | hist) . . (+38) . . N FOLFIRINOX (Created page with "== Metastatic Pancreatic Cancer ==")
- 09:57, 26 February 2012 (diff | hist) . . (+16) . . Pancreatic Cancer (current)
- 05:15, 23 February 2012 (diff | hist) . . (-241) . . m VMP (→Multiple Myeloma) (current)
- 05:14, 23 February 2012 (diff | hist) . . (+483) . . N VMP (Created page with "== Multiple Myeloma == Bortezomib 1.3 mg/m2 IV or SC. Given subcutaneously or as a rapid IV bolus over three to five seconds. Days 1, 8, 15, and 22 Melphalan 9 mg/m2 PO dai...")
- 05:08, 23 February 2012 (diff | hist) . . (+12) . . Multiple Myeloma And Plasma Cell Dyscrasias (→Bortezomib regimens)
- 23:59, 20 February 2012 (diff | hist) . . (+591) . . Cyclophosphamide Bortezomib Dexamethasone (→Reference) (current)
- 23:55, 20 February 2012 (diff | hist) . . (+10) . . m Multiple Myeloma And Plasma Cell Dyscrasias (→Bortezomib regimens)
- 23:54, 20 February 2012 (diff | hist) . . (+359) . . Cyclophosphamide Bortezomib Dexamethasone
- 21:43, 12 February 2012 (diff | hist) . . (+10) . . MediaWiki:Sidebar (current)
- 21:41, 12 February 2012 (diff | hist) . . (-8) . . MediaWiki:Sidebar
- 21:39, 12 February 2012 (diff | hist) . . (-514) . . Main Page
- 14:04, 12 February 2012 (diff | hist) . . (0) . . m Talk:Main Page (Protected "Talk:Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite))) (current)
- 14:04, 12 February 2012 (diff | hist) . . (0) . . m Main Page (Protected "Main Page" ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
- 10:30, 11 February 2012 (diff | hist) . . (+176) . . N MediaWiki:Common.css (Created page with "→CSS placed here will be applied to all skins: →Pad Google AdSense box in portlet in sidebar: #p-googleadsense .pBody { padding-top: 5px; text-align: center; }") (current)
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)
